(Q46623264)

23 December 2017

title

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial (English)

1 reference

23 December 2017

main subject

malaria

0 references

The Gambia

0 references

Plasmodium falciparum

0 references

1 reference

1 reference

1

1 reference

23 December 2017

David J. Conway

8

1 reference

23 December 2017

W Ripley Ballou

7

object named as

W R Ballou

1 reference

23 December 2017

author name string

P J Milligan

2

1 reference

23 December 2017

M Pinder

3

1 reference

23 December 2017

L Vigneron

4

1 reference

23 December 2017

A Alloueche

5

1 reference

23 December 2017

K E Kester

6

1 reference

23 December 2017

W H Reece

9

1 reference

23 December 2017

P Gothard

10

1 reference

23 December 2017

L Yamuah

11

1 reference

23 December 2017

M Delchambre

12

1 reference

23 December 2017

G Voss

13

1 reference

23 December 2017

B M Greenwood

14

1 reference

23 December 2017

A Hill

15

1 reference

23 December 2017

K P McAdam

16

1 reference

23 December 2017

N Tornieporth

17

1 reference

23 December 2017

J D Cohen

18

1 reference

23 December 2017

T Doherty

19

1 reference

23 December 2017

RTS, S Malaria Vaccine Trial Team

20

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

23 December 2017

published in

The Lancet

1 reference

23 December 2017

volume

358

1 reference

23 December 2017

page(s)

1927-1934

1 reference

23 December 2017

issue

9297

1 reference

23 December 2017

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Efficacy trial of malaria vaccine SPf66 in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 1. A review of the epidemiology and control of malaria in The Gambia, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Malaria prevalence is inversely related to vector density in The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Comparison of two simple methods for determining malaria parasite density

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

The impact of heterogeneity on the comparison of survival times.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Heterogeneity in survival analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

IgM antibody responses to the circumsporozoite protein in naturally acquired falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

Research toward vaccines against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906957-4

7 January 2021

10.1016/S0140-6736(01)06957-4

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

11747915

1 reference

23 December 2017